Your browser doesn't support javascript.
loading
Latin American Consensus on the Treatment of Head and Neck Cancer.
Matos, Leandro Luongo; Kowalski, Luiz Paulo; Chaves, Aline Lauda Freitas; de Oliveira, Thiago Bueno; Marta, Gustavo Nader; Curado, Maria Paula; de Castro Junior, Gilberto; Farias, Terence P; Bardales, Gustavo Sarria; Cabrera, Mario Avila; Capuzzo, Renato de Castro; de Carvalho, Genival Barbosa; Cernea, Claudio Roberto; Dedivitis, Rogério Aparecido; Dias, Fernando Luiz; Estefan, Andrés Munyo; Falco, Agustin Horacio; Ferraris, Gustavo Alberto; Gonzalez-Motta, Alejandro; Gouveia, Andre Guimarães; Jacinto, Alexandre Arthur; Kulcsar, Marco Aurelio Vamondes; Leite, Ana Kober; Lira, Renan Bezerra; Mak, Milena Perez; De Marchi, Pedro; de Mello, Evandro Sobroza; de Matos, Fátima Cristina Mendes; Montero, Pablo H; de Moraes, Eduardo Dias; de Moraes, Fabio Ynoe; Morais, Diego Chaves Rezende; Poenitz, Fernando Miguel; Poitevin, Adela; Riveros, Hernán Ortiz; Sanabria, Álvaro; Ticona-Castro, Miguel; Vartanian, José Guilherme; Viani, Gustavo; Vines, Eugenio F; William Junior, William Nassib; Conway, David; Virani, Shama; Brennan, Paul.
Affiliation
  • Matos LL; Head and Neck Surgery, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Universidade de São Paulo (Icesp HCFMUSP), São Paulo, Brazil.
  • Kowalski LP; Faculdade Israelita de Ciências da Saúde Albert Einstein, São Paulo, Brazil.
  • Chaves ALF; Universidade de São Paulo (FMUSP), São Paulo, Brazil.
  • de Oliveira TB; DOM Oncologia, Divinópolis, Brazil.
  • Marta GN; Head and Neck Cancer Reference Center-AC Camargo Cancer Center, São Paulo, Brazil.
  • Curado MP; Department of Radiation Oncology, Hospital Sírio-Libanês, São Paulo, Brazil.
  • de Castro Junior G; A C Camargo Cancer Center, São Paulo, Brazil.
  • Farias TP; Clinical Oncology, Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Universidade de São Paulo (Icesp HCFMUSP), São Paulo, Brazil.
  • Bardales GS; National Cancer Institute, Rio de Janeiro, Brazil.
  • Cabrera MA; INEN-AUNA, Lima, Peru.
  • Capuzzo RC; Head and Neck Surgeon, Lima, Peru.
  • de Carvalho GB; Barretos Cancer Hospital, Barretos, Brazil.
  • Cernea CR; A C Camargo Cancer Center, São Paulo, Brazil.
  • Dedivitis RA; University of São Paulo School of Medicine, São Paulo, Brazil.
  • Dias FL; Hospital das Clínicas, Universidade de São Paulo (HCFMUSP), São Paulo, Brazil.
  • Estefan AM; Brazilian National Cancer Institute, Rio de Janeiro, Brazil.
  • Falco AH; Profesor Adjunto Catedra de Otorrinolaringologia del Hospital de Clínicas, Montevidéu, Uruguay.
  • Ferraris GA; Instituto Alexander Fleming, Buenos Aires, Argentina.
  • Gonzalez-Motta A; Centro de Radioterapia Dean Funes, Córdoba, Argentina.
  • Gouveia AG; Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia.
  • Jacinto AA; Juravinski Cancer Centre, Department of Oncology, Division of Radiation Oncology, McMaster University, Hamilton, ON, Canada.
  • Kulcsar MAV; Barretos Cancer Hospital, Barretos, Brazil.
  • Leite AK; Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Universidade de São Paulo (Icesp HCFMUSP), São Paulo, Brazil.
  • Lira RB; Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas, Universidade de São Paulo (Icesp HCFMUSP), São Paulo, Brazil.
  • Mak MP; AC Camargo Cancer Center and Hospital Albert Einstein, São Paulo, Brazil.
  • De Marchi P; 3Instituto do Câncer do Estado de São Paulo, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, Brazil.
  • de Mello ES; 4Grupo Oncoclínicas, Rio de Janeiro, Brazil.
  • de Matos FCM; 5Department of Pathology, University of Sao Paulo School of Medicine, São Paulo, Brazil.
  • Montero PH; 6University of Pernambuco (UPE), Recife, Brazil.
  • de Moraes ED; Department of Surgical Oncology and Head and Neck Surgery, Division of Surgery, P. Universidad Católica de Chile, Santiago, Chile.
  • de Moraes FY; Grupo Oncoclínicas, Salvador, Brazil.
  • Morais DCR; Department of Oncology-Queen's University, Kingston, Canada.
  • Poenitz FM; 0Oncoclínicas Recife e Hospital Santa Águeda, Caruaru, Brazil.
  • Poitevin A; 1Head and Neck Surgeon, Rosario, Argentina.
  • Riveros HO; 2Medicasur, Mexico City, Mexico.
  • Sanabria Á; 3Instituto Nacional del Cancer, Hospital de Clinicas, Asunción, Paraguay.
  • Ticona-Castro M; 4Department of Surgery, Universidad de Antioquia, Hospital Alma Mater, Medellin, Colombia.
  • Vartanian JG; 5ESMO Member, Peruvian Society of Medical Oncology (S.P.O.M.) Member, La Molina, Peru.
  • Viani G; 6Head and Neck Surgery and Otorhinolaryngology Department, A. C. Camargo Cancer Center, São Paulo, Brazil.
  • Vines EF; 7Ribeirao Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.
  • William Junior WN; Facultad de Medicina, Pontificia Universidad Catolica de Chile, Santiago, Chile.
  • Conway D; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Virani S; University of Glasgow, Glasgow, Scotland.
  • Brennan P; International Agency for Research on Cancer (IARC/WHO), Genomic Epidemiology Branch, Lyon, France.
JCO Glob Oncol ; 10: e2300343, 2024 Apr.
Article in En | MEDLINE | ID: mdl-38603656
ABSTRACT
Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such as most countries in Latin America. International guidelines cannot always be applied to a population from a large region with specific conditions. This study established a Latin American guideline for care of patients with head and neck cancer and presented evidence of HNSCC management considering availability and oncologic benefit. A panel composed of 41 head and neck cancer experts systematically worked according to a modified Delphi process on (1) document compilation of evidence-based answers to different questions contextualized by resource availability and oncologic benefit regarding Latin America (region of limited resources and/or without access to all necessary health care system infrastructure), (2) revision of the answers and the classification of levels of evidence and degrees of recommendations of all recommendations, (3) validation of the consensus through two rounds of online surveys, and (4) manuscript composition. The consensus consists of 12 sections Head and neck cancer staging, Histopathologic evaluation of head and neck cancer, Head and neck surgery-oral cavity, Clinical oncology-oral cavity, Head and neck surgery-oropharynx, Clinical oncology-oropharynx, Head and neck surgery-larynx, Head and neck surgery-larynx/hypopharynx, Clinical oncology-larynx/hypopharynx, Clinical oncology-recurrent and metastatic head and neck cancer, Head and neck surgery-reconstruction and rehabilitation, and Radiation therapy. The present consensus established 48 recommendations on HNSCC patient care considering the availability of resources and focusing on oncologic benefit. These recommendations could also be used to formulate strategies in other regions like Latin America countries.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Head and Neck Neoplasms Limits: Humans Language: En Journal: JCO Glob Oncol Year: 2024 Type: Article Affiliation country: Brazil

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Head and Neck Neoplasms Limits: Humans Language: En Journal: JCO Glob Oncol Year: 2024 Type: Article Affiliation country: Brazil